US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cannara Biotech Inc.

1.37

0.0000

Volume:2.00

Turnover:2.72

Market Cap:130.87M

PE:15.53

High:1.37

Open:1.37

Low:1.37

Close:1.37

52wk High:1.47

52wk Low:0.7688

Shares:95.77M

Float Shares:45.28M

Volume Ratio:0.00

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.0880

ROE:11.70%

ROA:7.51%

PB:1.61

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Cannara Biotech announces conditional approval to list on TSX

Press Release: Cannara Reports Q1 Fiscal 2026 Results, Delivers New Record Financial Results, Extends Market Share Gains and Advances Disciplined Expansion Strategy

Cannara Biotech achieves OTCQX qualification

Press Release: Cannara Biotech Inc. to Announce Fiscal Q4 2025 and Fiscal Year 2025 Financial Results on November 24, 2025 and Provides Board Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LOVFF"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"LOVFF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LOVFF\",,,,,undefined,":{"symbol":"LOVFF","market":"US","secType":"STK","nameCN":"Cannara Biotech Inc.","latestPrice":1.3665,"timestamp":1770389687263,"preClose":1.3665,"halted":0,"volume":2,"delay":15,"changeRate":0,"floatShares":45277566,"shares":95767148,"eps":0.088,"marketStatus":"Market Closed","change":0,"latestTime":"02-06 09:54:47 EST Delay","open":1.3665,"high":1.3665,"low":1.3665,"amount":2.724,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.088,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"exchange":"OTCQX","adjPreClose":1.3665,"volumeRatio":0.0001357699515786922},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LOVFF\",,,,,undefined,":{"symbol":"LOVFF","floatShares":45277566,"roa":"7.51%","roe":"11.70%","lyrEps":0,"volumeRatio":0.0001357699515786922,"shares":95767148,"dividePrice":0,"high":1.3665,"amplitude":0,"preClose":1.3665,"low":1.3665,"week52Low":0.7688,"pbRate":"1.61","psRate":"1.60","week52High":1.47,"institutionHeld":0,"latestPrice":1.3665,"eps":0.088,"divideRate":0,"volume":2,"delay":15,"ttmEps":0.088,"open":1.3665,"prevYearClose":1.27,"prevWeekClose":1.29,"prevMonthClose":1.29,"prevQuarterClose":1.27,"fiveDayClose":1.29,"twentyDayClose":1.3,"sixtyDayClose":1.1825},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LOVFF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-25","symbol":"LOVFF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1732510800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-07-23","symbol":"LOVFF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1721707200000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-04-29","symbol":"LOVFF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1714363200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-01-29","symbol":"LOVFF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1706504400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-12-07","symbol":"LOVFF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1701925200000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LOVFF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LOVFF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1751864400000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LOVFF\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606711118","title":"Cannara Biotech announces conditional approval to list on TSX","url":"https://stock-news.laohu8.com/highlight/detail?id=2606711118","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606711118?lang=en_us&edition=fundamental","pubTime":"2026-01-28 21:17","pubTimestamp":1769606259,"startTime":"0","endTime":"0","summary":"Cannara Biotech (LOVFF) has received conditional approval to uplist its common shares to the Toronto Stock Exchange from the TSX Venture Exchange. ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cannara-biotech-announces-conditional-approval-to-list-on-tsx-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cannara-biotech-announces-conditional-approval-to-list-on-tsx-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LOVFF","LABU","BK4007","BK4588","BK4585","BK4183"],"gpt_icon":0},{"id":"2606212076","title":"Press Release: Cannara Reports Q1 Fiscal 2026 Results, Delivers New Record Financial Results, Extends Market Share Gains and Advances Disciplined Expansion Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2606212076","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606212076?lang=en_us&edition=fundamental","pubTime":"2026-01-26 20:02","pubTimestamp":1769428920,"startTime":"0","endTime":"0","summary":"-- New Record Financial Results: Total revenues of $30.1 million, gross. profit before fair value adjustments of $13.5 million or 45% and Adjusted. EBITDA of $8.8 million1, supported by operating cash flows of $8.0. million and free cash flow of $3.3 million2.-- Extends Market Share Gains: Estimated national retail market share. reached 4.1% in Q1 2026, up from 3.8% in Q4 2025, driven by strong. momentum across key provinces, including Québec, where Cannara. ranked #1 by December 2025 following the successful vape launch, and. remains on budget and on track for completion in Fiscal 2026, while the. cultivation-ready at the start of Fiscal 2027 to support anticipated. \"Our Q1 2026 financial results demonstrate the effectiveness of our operating model and our continued focus on efficiency and profitability, \" commented Nicholas Sosiak, Chief Financial Officer of Cannara. \"Gross cannabis revenues increased 20%, gross profit before fair value adjustments rose by 38% and adjus","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","LOVFF","BK4007"],"gpt_icon":0},{"id":"2603990614","title":"Cannara Biotech achieves OTCQX qualification","url":"https://stock-news.laohu8.com/highlight/detail?id=2603990614","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603990614?lang=en_us&edition=fundamental","pubTime":"2026-01-14 22:11","pubTimestamp":1768399894,"startTime":"0","endTime":"0","summary":"Cannara Biotech (LOVFF) has qualified to have its common shares quoted for trading on the OTCQX Best Market. Cannara’s common shares were previousl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cannara-biotech-achieves-otcqx-qualification-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cannara-biotech-achieves-otcqx-qualification-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4183","LOVFF"],"gpt_icon":0},{"id":"2584628845","title":"Press Release: Cannara Biotech Inc. to Announce Fiscal Q4 2025 and Fiscal Year 2025 Financial Results on November 24, 2025 and Provides Board Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2584628845","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584628845?lang=en_us&edition=fundamental","pubTime":"2025-11-17 20:08","pubTimestamp":1763381280,"startTime":"0","endTime":"0","summary":"MONTREAL, Nov. 17, 2025  -- Cannara Biotech Inc.    , a vertically integrated producer of premium-grade cannabis products at disruptive prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced that it will release its financial results for the fiscal fourth quarter and fiscal year ended August 31, 2025, on Monday, November 24, 2025, at 7:00 a.m. ET.For interested individuals unable to join, the event will be archived on the company's website.Investors are encouraged to submit questions in advance to investors@cannara.ca. While live questions will be accepted during the session, priority will be given to those submitted by email.Cannara would also like to announce with great sadness the passing of Jack M. Kay, a long-serving and highly respected member of the Board of Directors. Mr. Kay, who joined the Board in 2019, contributed more than five decades of leadership experience in pharmaceutical and sales executive management to the Corporation.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4183","LOVFF"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/LOVFF\",params:#limit:6,delay:false,,,undefined,":[]}}